Ads
related to: UTHR Stocknerdwallet.com has been visited by 100K+ users in the past month
Search results
The 3 Best Medical Device Stocks to Buy in June 2024
InvestorPlace· 5 hours agoMedical devices are spearheading the digitalization of healthcare, reports analytics and software development company Luxoft. Specifically, medical...
Martine A. Rothblatt Sells 3,600 Shares of United Therapeutics Co. (NASDAQ:UTHR) Stock
ETF DAILY NEWS· 2 days agoUnited Therapeutics Co. (NASDAQ:UTHR – Get Free Report) CEO Martine A. Rothblatt sold 3,600 shares of the company’s stock in a transaction on Friday, June ...
Intra-Cellular Therapies Stock Scores RS Rating Upgrade To 87
Investor's Business Daily· 6 hours agoThe Relative Strength (RS) Rating for Intra-Cellular Therapies stock entered a new percentile...
Insider Sale: Director Judy Olian Sells Shares of United Therapeutics Corp (UTHR)
GuruFocus.com via Yahoo Finance· 2 days agoJudy Olian sold 1,700 shares of United Therapeutics Corp (NASDAQ:UTHR) on June 17, 2024, as reported...
Insider Sale: Director Christopher Causey Sells Shares of United Therapeutics Corp (UTHR) By...
Investing.com· 6 days agoFollowing this transaction, the insider now owns 4,185 shares of the company. United...chronic and...
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Zacks via Yahoo Finance· 3 days agoThis investing style is all about taking advantage of upward or downward trends in a stock's price...
10 Health Care Stocks Whale Activity In Today's Session - Community Health Sys (NYSE:CYH),...
Benzinga· 1 day ago...BULLISH 06/21/24 $530.00 $30.2K 420 28 TDOC PUT SWEEP BEARISH 01/17/25 $15.00 $26.4K 1.9K 26 DHR PUT SWEEP BULLISH 01/17/25 $260.00 $35.2K 654 20 UTHR CALL SWEEP BEARISH 08/16/24 $320.00 $55.6K 25 5 Explanation These bullet-by-bullet explanations have been constructed using the accompanying...
Neurocrine Biosciences Stock Tops Milestone Amid New Drug Plans
Investor's Business Daily· 6 days agoNeurocrine Biosciences (NBIX) continues to put up really healthy numbers, with an ostensible 335% profit hike on a powerful reversal last quarter. The upgraded 82 RS Rating means Neurocrine ...